In Vitro Studies. Small Animal Studies. Radiopharmacology and Radiopharmacy. Case Studies on Developing Target Nonnuclear Probes. Case Studies on Developing Targeted Radiotracers.
Dr. Michael J. Welch is Professor of Radiology, Professor of Chemistry, Professor of Developmental Biology and Professor of Biomedical Engineering at Washington University, St. Louis. He is a recipient of many honors; these include the Paul C. Aebersold Award, the Georg Charles de Hevesy NuclearPioneer Award and the Cassen Prize from the Society of Nuclear Medicine and the St. Louis Award, the Midwest Award and the National Award for Nuclear Chemistry from the American Chemical Society. He has served as President of the Society of Nuclear Medicine and in 1999 was elected to the Institute of Medicine of the National Academy of Sciences. Dr. Welch received a bachelor’s degree from Cambridge University, England and a Ph.D. in Radiochemistry from Queen Mary College, London. His primary research interests involve the development of novel PET agents, particularly targeting cancer and cardiac disease.
Dr. William C. Eckelman is presently Professor of Radiology at UCSD and the president of Molecular Tracer LLC. A pioneer in Tc-99m radiopharmaceutical development, he and colleagues developed the Instant Tc-99m Kit, which became the basis for all subsequent 99mTc radiopharmaceutical kits, and targeted receptor-binding radiotracers for human use for both SPECT and PET, including the first neuroreceptor image in humans. Dr. Eckelman has been the editor-in-chief of Nuclear Medicine and Biology since 1985. He received numerous awards including the Paul C. Aebersold Award, the Institute of Clinical PET Distinguished Scientist Award, the American College of Nuclear Physicians Corporate Achievement Award, the Georg deHevesy Nuclear Pioneer Award, the Great Golden Seal of Padua University in recognition of contributions to Radiopharmaceutical Development and the Society of Radiopharmaceutical Sciences President’s Award.
"… a timely resource for a rapidly advancing field, giving a
comprehensive account of the state of the art in disease modelling,
imaging studies in animals, imaging in initial human studies, and
the application of molecular imaging in pharmacy and drug
discovery. … a helpful tool for all readers involved with targeted
molecular imaging, medical chemistry, pharmacology, radiology, and
medical physics. It would also be a valuable text for graduate
students, postdoctoral fellows, and junior faculty members who are
becoming involved in this rapidly expanding field … edited by two
masters in the field."
—Luigi Mansi and Davide d’Arienzo, European Journal of Nuclear
Medicine and Molecular Imaging, Vol. 40, 2013"… this book is a must
for new investigators in the field. Even seasoned investigators are
strongly encouraged to consult sections of the book often in order
to insure their own studies are complete. Especially important is
the interdisciplinary approach utilized in the case studies. This
book could also be a valuable resource in graduate classes or as a
basis for a continuing education class. The book was written with
foresight, such that it can be considered a timeless addition to
anyone’s collection. Many, many costly pitfalls can be avoided
through thoughtful review of the information contained within this
reference."
—Susan Z. Lever, Journal of Labelled Compounds and
Radiopharmaceuticals, 2012"This text successfully fulfills its goal
by introducing the concepts of molecular imaging agent development
and then providing a diverse set of examples of targeted agents. …
The strength of this book is its emphasis of case studies that are
representative of the various types of translational studies that
can be performed using molecular imaging."
—Michael T. Munley, Medical Physics, August 2012
|
Ask a Question About this Product More... |
|
